01 March 2023
Report on the results of sale of common shares offered to employee stock option program (F53-5)
23 February 2023
Resolutions of the Board Meeting No. 1/2023 regarding issuance and offering of new shares to directors, executives and employees, capital reduction, capital increase, schedule and agenda of 2023 AGM and the omission of dividend payment
23 February 2023
Financial Statement Yearly 2022 (Audited) (revised notes to financial statements no.37)
22 February 2023
Resolutions of the Board Meeting No. 1/2023 regarding issuance and offering of new shares to directors, executives and employees, capital reduction, capital increase, schedule and agenda of 2023 AGM and the omission of dividend payment
22 February 2023
Management Discussion and Analysis Yearly Ending 31 Dec 2022
22 February 2023
Financial Performance Yearly (F45) (Audited)
22 February 2023
Financial Statement Yearly 2022 (Audited)
09 February 2023
New shares of BC to be traded on February 10, 2023
08 February 2023
Report on the results of sale of common shares offered to employee stock option program (F53-5)
20 January 2023
Report on the utilization of proceeds from capital increase for the period ended 31 December 2022
17 January 2023
Report on the results of the Exercise of BC-ESOP-W1 (F53-5) (Revised)
06 January 2023
Report on the results of the Exercise of BC-ESOP-W1 (F53-5)